Quest Diagnostics Files Q3 2024 10-Q
Ticker: DGX · Form: 10-Q · Filed: 2024-10-23T00:00:00.000Z
Sentiment: neutral
Topics: 10-Q, financials, quarterly-report
TL;DR
Quest Diagnostics Q3 10-Q is in: financials updated, check for revenue and net income trends.
AI Summary
Quest Diagnostics Inc. filed its 10-Q for the period ending September 30, 2024. The filing provides financial details for the third quarter and the first nine months of the year, including revenue and net income figures. Specific balance sheet items and changes in equity are also detailed, reflecting the company's financial position.
Why It Matters
This filing provides investors and analysts with the latest financial performance and position of Quest Diagnostics, crucial for understanding the company's operational health and future outlook.
Risk Assessment
Risk Level: low — This is a routine quarterly financial filing with no immediate red flags.
Key Numbers
- N/A — Revenue (Specific revenue figures for Q3 2024 are not explicitly listed in the provided text snippet.)
- N/A — Net Income (Specific net income figures for Q3 2024 are not explicitly listed in the provided text snippet.)
Key Players & Entities
- Quest Diagnostics Inc. (company) — Filer of the 10-Q
- 2024-09-30 (date) — End of the reporting period
- 2024-10-23 (date) — Filing date
FAQ
What were Quest Diagnostics' total revenues for the nine months ended September 30, 2024?
The provided text does not explicitly state the total revenues for the nine months ended September 30, 2024.
What is the company's reported net income for the third quarter of 2024?
The provided text does not explicitly state the net income for the third quarter of 2024.
When was Quest Diagnostics Inc. incorporated?
Quest Diagnostics Inc. was incorporated in Delaware (DE).
What is the company's principal business address?
The principal business address is 500 Plaza Drive, Secaucus, NJ 07094.
What was the previous name of Quest Diagnostics Inc.?
The previous name was Corning Clinical Laboratories Inc., with a date of name change on 19960903.
From the Filing
0001022079-24-000190.txt : 20241023 0001022079-24-000190.hdr.sgml : 20241023 20241023172433 ACCESSION NUMBER: 0001022079-24-000190 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 74 CONFORMED PERIOD OF REPORT: 20240930 FILED AS OF DATE: 20241023 DATE AS OF CHANGE: 20241023 FILER: COMPANY DATA: COMPANY CONFORMED NAME: QUEST DIAGNOSTICS INC CENTRAL INDEX KEY: 0001022079 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 161387862 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-12215 FILM NUMBER: 241390122 BUSINESS ADDRESS: STREET 1: 500 PLAZA DRIVE CITY: SECAUCUS STATE: NJ ZIP: 07094 BUSINESS PHONE: 9735202700 MAIL ADDRESS: STREET 1: 500 PLAZA DRIVE CITY: SECAUCUS STATE: NJ ZIP: 07094 FORMER COMPANY: FORMER CONFORMED NAME: CORNING CLINICAL LABORATORIES INC DATE OF NAME CHANGE: 19960903 10-Q 1 dgx-20240930.htm 10-Q dgx-20240930 0001022079 12/31 2024 Q3 FALSE 461 360 350 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure iso4217:CAD dgx:claim 0001022079 2024-01-01 2024-09-30 0001022079 2024-10-15 0001022079 2024-07-01 2024-09-30 0001022079 2023-07-01 2023-09-30 0001022079 2023-01-01 2023-09-30 0001022079 2024-09-30 0001022079 2023-12-31 0001022079 2022-12-31 0001022079 2023-09-30 0001022079 us-gaap:CommonStockMember 2024-06-30 0001022079 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0001022079 us-gaap:RetainedEarningsMember 2024-06-30 0001022079 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-06-30 0001022079 us-gaap:TreasuryStockCommonMember 2024-06-30 0001022079 us-gaap:NoncontrollingInterestMember 2024-06-30 0001022079 2024-06-30 0001022079 us-gaap:RetainedEarningsMember 2024-07-01 2024-09-30 0001022079 us-gaap:NoncontrollingInterestMember 2024-07-01 2024-09-30 0001022079 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-07-01 2024-09-30 0001022079 us-gaap:AdditionalPaidInCapitalMember 2024-07-01 2024-09-30 0001022079 us-gaap:TreasuryStockCommonMember 2024-07-01 2024-09-30 0001022079 us-gaap:CommonStockMember 2024-07-01 2024-09-30 0001022079 us-gaap:CommonStockMember 2024-09-30 0001022079 us-gaap:AdditionalPaidInCapitalMember 2024-09-30 0001022079 us-gaap:RetainedEarningsMember 2024-09-30 0001022079 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-09-30 0001022079 us-gaap:TreasuryStockCommonMember 2024-09-30 0001022079 us-gaap:NoncontrollingInterestMember 2024-09-30 0001022079 us-gaap:CommonStockMember 2023-12-31 0001022079 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001022079 us-gaap:RetainedEarningsMember 2023-12-31 0001022079 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001022079 us-gaap:TreasuryStockCommonMember 2023-12-31 0001022079 us-gaap:NoncontrollingInterestMember 2023-12-31 0001022079 us-gaap:RetainedEarningsMember 2024-01-01 2024-09-30 0001022079 us-gaap:NoncontrollingInterestMember 2024-01-01 2024-09-30 0001022079 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-09-30 0001022079 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-09-30 0001022079 us-gaap:TreasuryStockCommonMember 2024-01-01 2024-09-30 0001022079 us-gaap:CommonStockMember 2024-01-01 2024-09-30 0001022079 us-gaap:CommonStockMember 2023-06-30 0001022079 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001022079 us-gaap:RetainedEarningsMember 2023-06-30 0001022079 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-06-30 0001022079 us-gaap:TreasuryStockCommonMember 2023-06-30 0001022079 us-gaap:NoncontrollingInterestMember 2023-06-30 0001022079 2023-06-30 0001022079 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0001022079 us-gaap:NoncontrollingInterestMember 2023-07-01 2023-09-30 0001022079 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-07-01 2023-09-30 0001022079 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0001022079 us-gaap:TreasuryStockCommonMember 2023-07-01 2023-09-30 00010